155 related articles for article (PubMed ID: 32280839)
1. Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome.
Gipson DS; Trachtman H; Waldo A; Gibson KL; Eddy S; Dell KM; Srivastava T; Lemley KV; Greenbaum LA; Hingorani S; Meyers KE; Kaskel FJ; Reidy KJ; Sethna CB; Tran CL; Wang CS; Tuttle KR; Oh G; Neu AM; Brown E; Lin JJ; Yee JL; Roth TM; Troost JP; Gillespie BW; Sampson MG; Kretzler M; Ju W
Kidney Int Rep; 2020 Apr; 5(4):414-425. PubMed ID: 32280839
[TBL] [Abstract][Full Text] [Related]
2. Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children.
Li B; Zhang Y; Wang F; Nair V; Ding F; Xiao H; Yao Y; Kretzler M; Ju W; Ding J
Pediatr Nephrol; 2018 Oct; 33(10):1731-1739. PubMed ID: 29948307
[TBL] [Abstract][Full Text] [Related]
3. Urinary epidermal growth factor predicts complete remission of proteinuria in Chinese children with IgA nephropathy.
Zhou J; Sun S; Zhang D; Mao J; Xiao H; Yao Y; Wang F; Yu L; Liu L; Feng C; Li C; Su B; Zhang H; Liu X; Xu K; Ju W; Zhong X; Ding J
Pediatr Res; 2023 Aug; 94(2):747-755. PubMed ID: 36864281
[TBL] [Abstract][Full Text] [Related]
4. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
[TBL] [Abstract][Full Text] [Related]
5. Biopsy or Biomarker? Children With Minimal Change Disease Have a Distinct Profile of Urinary Epidermal Growth Factor.
Lodeweyckx N; Wouters K; Ledeganck KJ; Trouet D
Front Pediatr; 2021; 9():727954. PubMed ID: 34900856
[No Abstract] [Full Text] [Related]
6. Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis.
Wu L; Li XQ; Goyal T; Eddy S; Kretzler M; Ju WJ; Chen M; Zhao MH
Ann Rheum Dis; 2018 Sep; 77(9):1339-1344. PubMed ID: 29724728
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and epidermal growth factor as noninvasive biomarkers of progression in chronic glomerulonephritis.
Idasiak-Piechocka I; Miedziaszczyk M; Woźniak A; Pawliczak E; Kaczmarek E; Oko A
Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1267-C1275. PubMed ID: 37721004
[TBL] [Abstract][Full Text] [Related]
8. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
Azukaitis K; Ju W; Kirchner M; Nair V; Smith M; Fang Z; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Yalcinkaya F; Paripovic D; Harambat J; Cakar N; Alpay H; Lugani F; Mencarelli F; Civilibal M; Erdogan H; Gellermann J; Vidal E; Tabel Y; Gimpel C; Ertan P; Yavascan O; Melk A; Querfeld U; Wühl E; Kretzler M; Schaefer F; ;
Kidney Int; 2019 Jul; 96(1):214-221. PubMed ID: 31005273
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of epidermal growth factor and rapid loss of kidney function.
Norvik JV; Harskamp LR; Nair V; Shedden K; Solbu MD; Eriksen BO; Kretzler M; Gansevoort RT; Ju W; Melsom T
Nephrol Dial Transplant; 2021 Sep; 36(10):1882-1892. PubMed ID: 33068410
[TBL] [Abstract][Full Text] [Related]
10. Associations of Serum Uromodulin and Urinary Epidermal Growth Factor with Measured Glomerular Filtration Rate and Interstitial Fibrosis in Kidney Transplantation.
Chan J; Svensson M; Tannæs TM; Waldum-Grevbo B; Jenssen T; Eide IA
Am J Nephrol; 2022; 53(2-3):108-117. PubMed ID: 35104815
[TBL] [Abstract][Full Text] [Related]
11. The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
Menez S; Wen Y; Xu L; Moledina DG; Thiessen-Philbrook H; Hu D; Obeid W; Bhatraju PK; Ikizler TA; Siew ED; Chinchilli VM; Garg AX; Go AS; Liu KD; Kaufman JS; Kimmel PL; Himmelfarb J; Coca SG; Cantley LG; Parikh CR
Kidney Int; 2023 Dec; 104(6):1194-1205. PubMed ID: 37652206
[TBL] [Abstract][Full Text] [Related]
12. Urinary Epidermal Growth Factor/Creatinine Ratio and Graft Failure in Renal Transplant Recipients: A Prospective Cohort Study.
Yepes-Calderón M; Sotomayor CG; Kretzler M; Gans ROB; Berger SP; Navis GJ; Ju W; Bakker SJL
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31614925
[TBL] [Abstract][Full Text] [Related]
13. Urinary Epidermal Growth Factor: A Promising "Next Generation" Biomarker in Kidney Disease.
Cortvrindt C; Speeckaert R; Delanghe JR; Speeckaert MM
Am J Nephrol; 2022; 53(5):372-387. PubMed ID: 35537382
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.
Li Z; Zhao Z; Liu X; Su Z; Shang X; Wen J
Pediatr Nephrol; 2012 Dec; 27(12):2251-9. PubMed ID: 22773267
[TBL] [Abstract][Full Text] [Related]
15. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.
Ju W; Nair V; Smith S; Zhu L; Shedden K; Song PXK; Mariani LH; Eichinger FH; Berthier CC; Randolph A; Lai JY; Zhou Y; Hawkins JJ; Bitzer M; Sampson MG; Thier M; Solier C; Duran-Pacheco GC; Duchateau-Nguyen G; Essioux L; Schott B; Formentini I; Magnone MC; Bobadilla M; Cohen CD; Bagnasco SM; Barisoni L; Lv J; Zhang H; Wang HY; Brosius FC; Gadegbeku CA; Kretzler M;
Sci Transl Med; 2015 Dec; 7(316):316ra193. PubMed ID: 26631632
[TBL] [Abstract][Full Text] [Related]
16. Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease.
Drexler Y; Molina J; Elfassy T; Ma R; Christoffersen C; Kurano M; Yatomi Y; Mariani LH; Contreras G; Merscher S; Fornoni A
Kidney Int Rep; 2023 Apr; 8(4):884-897. PubMed ID: 37069998
[TBL] [Abstract][Full Text] [Related]
17. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.
Mariani LH; Martini S; Barisoni L; Canetta PA; Troost JP; Hodgin JB; Palmer M; Rosenberg AZ; Lemley KV; Chien HP; Zee J; Smith A; Appel GB; Trachtman H; Hewitt SM; Kretzler M; Bagnasco SM
Nephrol Dial Transplant; 2018 Feb; 33(2):310-318. PubMed ID: 28339906
[TBL] [Abstract][Full Text] [Related]
18. The association of low birthweight and prematurity on outcomes in children and adults with nephrotic syndrome-a NEPTUNE cohort study.
Hingorani S; Gibson KL; Xie Y; Wang Y; Eddy S; Hartman J; Sampson M; Cassol C; Thomas D; Gipson DS; Trachtman H; Srivastava T; Reidy K;
Pediatr Nephrol; 2023 Oct; 38(10):3297-3308. PubMed ID: 37140708
[TBL] [Abstract][Full Text] [Related]
19. Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.
de Cos M; Mosoyan G; Chauhan K; Troost JP; Wong JS; Lefferts S; Morgan P; Meliambro K; Egerman M; Ray J; Parker T; Levine D; Seshan S; Bardash Y; Horowitz B; Kent CA; Shaw MM; Perlman A; Moledina DG; Coca SG; Campbell KN
Am J Kidney Dis; 2024 Mar; ():. PubMed ID: 38452919
[TBL] [Abstract][Full Text] [Related]
20. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
